CDH5 and hepatocellular carcinoma: Circulating EPC elevation with phenotype CD144+/CD34+/CD133+/CD45− was found in hepatic carcinoma patients and seemed to be positively correlate with tumor burden, suggesting potentials in cbLB biomarker translation (see HSC) [93].